Igor Bilinsky - 04 Mar 2024 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role: Chief Operating Officer
Signature: /s/ Igor Bilinsky
Issuer symbol: IOVA
Transactions as of: 04 Mar 2024
Net transactions value: -$123,588
Form type: 4
Filing time: 06 Mar 2024, 18:17:22 UTC
Previous filing: 05 Mar 2024
Next filing: 17 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IOVA	Common Stock	Options Exercise	$0	+14,061	+47%	$0.000000	43,928	04 Mar 2024	Direct	F1
transaction	IOVA	Common Stock	Tax liability	$123,588	-7,287	-17%	$16.96	36,641	04 Mar 2024	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IOVA	Restricted Stock Units	Options Exercise	$0	-14,061	-33%	$0.000000	28,129	04 Mar 2024	Common stock	14,061		Direct	F4, F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
F2	Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
F3	Represents common stock remaining after deducting the common stock withheld for taxes.
F4	Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F5	The remaining RSUs will vest in equal quarterly installments.
F6	Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.